key: cord-0891226-2kj3nits
authors: Warden, Alyssa; Caldera, Kristin
title: The Essential Role of a Physiatrist in Recommending a COVID‐19 Vaccine
date: 2021-02-28
journal: PM R
DOI: 10.1002/pmrj.12582
sha: 1f39c5a499743074739fe24980eb5d99ec845431
doc_id: 891226
cord_uid: 2kj3nits

nan

Over 400,000 people in the United States have died due to COVID-19, with the numbers continuing to rise. 2 The Food and Drug Administration (FDA) evaluated the scientific data of two large phase three clinical trials for COVID-19 vaccines. 2 Once determining safety and efficacy, they granted Emergency Use Authorization (EUA) of these vaccines in December 2020. 2 The Center for Disease Control and Prevention (CDC) and the Advisory Committee on Immunization Practices (ACIP) then provided recommendations about who should receive the vaccine. 2 These meetings were open and transparent to the public. 2 The AICP provided recommendations to states on an equitable distribution plan with multiple phases. 2 There has been a notable response from the US population regarding vaccine hesitancy since even before the vaccines were completed, with a poll in April 2020 revealing only 57.6% of poll participants intending to be vaccinated. 4 Concerns about vaccine novelty and safety are This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/pmrj.12582 commonly cited reasons for being unsure about accepting vaccination, followed by lack of trust and misconceptions about COVID-19 vaccines. 4 Now that the vaccination process has begun, we will likely continue to see the effects of vaccine hesitancy and its impact on COVID-19 vaccination rates.

Physiatrists are in a unique position to provide education given that they care for patients with complex and chronic conditions, and often have established relationships with these patients and their caregivers. Patients with neurologic injury resulting in cognitive or physical impairment may be living in long-term care facilities or have multiple caregivers, and as a result, have an increased risk for contracting COVID-19. Populations cared for by physiatrists, such as those with spinal cord injuries, have lower influenza vaccination rates compared with the general population. 5 In addition, due to the nature of performing recurring procedures such as botulinum toxin injections, baclofen pump refills, and addressing pain and functional decline, patients are sometimes seen more frequently by their physiatrist than their primary care provider. This yields the opportunity to educate patients and their caregivers, and have insightful discussion about the safety and efficacy of COVID-19 vaccines in a setting with an already trusted physician-patient relationship.

Health care provider recommendations for vaccination are strongly associated with a patient's receipt of vaccines. 6 Additionally, having knowledge or awareness of the influenza vaccination recommendation was significantly associated with a higher level of influenza vaccination, 6 a concept that can theoretically be shared with COVID-19 vaccination, as having knowledge or awareness of vaccine recommendations might indicate a propensity to seek and accept vaccination. 6

The first step to improving patients' vaccine uptake should be to have an open conversation regarding patients' and their caregivers' hesitations toward the COVID-19 vaccine. Ask open-ended questions such as "Do you have any questions or concerns about the COVID-19 vaccines?". Clinicians should be knowledgeable about the approval of the vaccine and its safety and efficacy. While the vaccines were made available through EUA, the scientific process was honored and the CDC and ACIP are recommending vaccination. 2 Both available vaccines have been shown to be effective after a two-dose series. 2 Most post-vaccination symptoms are mild to moderate, occur within the first three days of vaccination, and resolve within 1-3 days of onset. 2 It is important to emphasize to patients that the benefits of these vaccines outweigh the risks of becoming infected with COVID-19, and to make a strong recommendation for vaccination provided patients have no contraindications. It may be beneficial for providers to discuss their personal experience getting their own COVID-19 vaccination. Whether visits are via telemedicine or in-person, physiatrists should play an active role in improving education regarding COVID-19 vaccination to potentially increase uptake of the vaccine in their patient population.

When Disparities and Disabilities Collide: Inequities During the COVID-19 Pandemic

Attitudes toward a potential SARS-CoV-2 vaccine: A survey of U.S. adults

Preventive health care among communitydwelling persons with spinal cord injury

Association of provider recommendation and offer and influenza vaccination among adults aged ≥18 years -United States. Vaccine